Serum India, Bharat Biotech to test intranasal COVID-19 vaccines post regulatory nod: Dr Harsh… EP News Bureau Oct 19, 2020 He clarified that Phase III clinical trial is generally with thousands of participants, sometimes even close to 30,000 to 40,000…
